These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17236878)

  • 1. Erythromycin for treatment of feeding intolerance in preterm infants.
    Su BH; Lin HC
    J Pediatr; 2007 Feb; 150(2):e30; author reply e31. PubMed ID: 17236878
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythromycin for treatment of feeding intolerance in preterm infants.
    Mascarenhas S; Lal M
    J Pediatr; 2007 Feb; 150(2):e30-1; author reply e31. PubMed ID: 17236879
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral erythromycin for treatment of feeding intolerance in preterm infants: a preliminary report.
    Sekteera W; Nuntnarumit P; Supapannachart S
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1177-82. PubMed ID: 12549792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of oral erythromycin for treatment of feeding intolerance in preterm infants.
    Nuntnarumit P; Kiatchoosakun P; Tantiprapa W; Boonkasidecha S
    J Pediatr; 2006 May; 148(5):600-5. PubMed ID: 16737869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled trial of a high dose of oral erythromycin for the treatment of feeding intolerance in preterm infants.
    Mansi Y; Abdelaziz N; Ezzeldin Z; Ibrahim R
    Neonatology; 2011; 100(3):290-4. PubMed ID: 21701222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of oral erythromycin for the treatment of gastrointestinal dysmotility in preterm infants.
    Ng PC
    Neonatology; 2009; 95(2):97-104. PubMed ID: 19218823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythromycin fails to improve feeding outcome in feeding-intolerant preterm infants.
    ElHennawy AA; Sparks JW; Armentrout D; Huseby V; Berseth CL
    J Pediatr Gastroenterol Nutr; 2003 Sep; 37(3):281-6. PubMed ID: 12960650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled trial of erythromycin and UDCA in premature infants during parenteral nutrition in minimizing feeding intolerance and liver function abnormalities.
    Gokmen T; Oguz SS; Bozdag S; Erdeve O; Uras N; Dilmen U
    J Perinatol; 2012 Feb; 32(2):123-8. PubMed ID: 21566568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythromycin and feeding intolerance in premature infants: a randomized trial.
    Aly H; Abdel-Hady H; Khashaba M; El-Badry N
    J Perinatol; 2007 Jan; 27(1):39-43. PubMed ID: 17036029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of prokinetics in the preterm infant.
    Lam HS; Ng PC
    Curr Opin Pediatr; 2011 Apr; 23(2):156-60. PubMed ID: 21178622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythromycin as a prokinetic agent in newborns--useful or doubtful. Commentary on Y. Mansi et al.: Randomized controlled trial of a high dose of oral erythromycin for the treatment of feeding intolerance in preterm infants (Neonatology 2011;100:290-294).
    Ng PC
    Neonatology; 2011; 100(3):297-8. PubMed ID: 21701224
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of prophylactic oral erythromycin to improve enteral feeding tolerance in preterm infants: a randomised controlled study.
    Mohammadizadeh M; Ghazinour M; Iranpour R
    Singapore Med J; 2010 Dec; 51(12):952-6. PubMed ID: 21221501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisapride: a review of the evidence supporting its use in premature infants with feeding intolerance.
    Premji SS; Wilson J; Paes B; Gray S
    Neonatal Netw; 1997 Oct; 16(7):17-21. PubMed ID: 9369691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An approach to using recombinant erythropoietin for neuroprotection in very preterm infants.
    Fauchère JC; Dame C; Vonthein R; Koller B; Arri S; Wolf M; Bucher HU
    Pediatrics; 2008 Aug; 122(2):375-82. PubMed ID: 18676556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythromycin treatment for gastrointestinal dysmotility in preterm infants.
    Ng PC; Fok TF; Lee CH; Wong W; Cheung KL
    J Paediatr Child Health; 1997 Apr; 33(2):148-50. PubMed ID: 9145359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythromycin as a prokinetic agent in preterm neonates: a systematic review.
    Patole S; Rao S; Doherty D
    Arch Dis Child Fetal Neonatal Ed; 2005 Jul; 90(4):F301-6. PubMed ID: 15899929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous low-dose erythromycin administration for infants with feeding intolerance.
    Nogami K; Nishikubo T; Minowa H; Uchida Y; Kamitsuji H; Takahashi Y
    Pediatr Int; 2001 Dec; 43(6):605-10. PubMed ID: 11737737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between plasma levels of vasoactive intestinal peptide and feeding intolerance in preterm infants].
    Xu J; Huang RZ; Huang JW; Liu GS
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Jun; 13(6):451-4. PubMed ID: 21672415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Optimal dosage of orotic acid in the treatment of toxic hyperbilirubinemia in premature infants].
    Hinkel GK; Schwarze R; Kintzel HW
    Acta Paediatr Acad Sci Hung; 1972; 13(4):367-75. PubMed ID: 4664664
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experiences with the use of gentamicin in newborn and premature infants].
    Limoli S; Longo R
    G Ital Chemioter; 1969; 16(1):274-6. PubMed ID: 5404105
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.